A detailed history of Seven Mile Advisory transactions in Novo Nordisk A S stock. As of the latest transaction made, Seven Mile Advisory holds 7,118 shares of NVO stock, worth $783,905. This represents 0.75% of its overall portfolio holdings.

Number of Shares
7,118
Previous 7,143 0.35%
Holding current value
$783,905
Previous $917 Million 10.78%
% of portfolio
0.75%
Previous 0.7%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

SELL
$122.71 - $146.91 $3,067 - $3,672
-25 Reduced 0.35%
7,118 $1.02 Billion
Q1 2024

May 08, 2024

BUY
$102.11 - $135.92 $27,876 - $37,106
273 Added 3.97%
7,143 $917 Million
Q4 2023

Feb 09, 2024

BUY
$87.78 - $105.45 $17,731 - $21,300
202 Added 3.03%
6,870 $711 Million
Q3 2023

Nov 13, 2023

BUY
$90.94 - $199.54 $335,841 - $736,901
3,693 Added 124.13%
6,668 $606 Million
Q2 2023

Aug 08, 2023

BUY
$155.98 - $172.65 $464,040 - $513,633
2,975 New
2,975 $481 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $249B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Seven Mile Advisory Portfolio

Follow Seven Mile Advisory and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Seven Mile Advisory, based on Form 13F filings with the SEC.

News

Stay updated on Seven Mile Advisory with notifications on news.